XX
ocds-bidanga-XX-290410
Evaluation of Lateral Flow Tests for Rubella IgM Detection for Surveillance
Titre original : REOI for WHO Evaluation of lateral flow immunoassays (LFTs) for Detection of Rubella IgM for Surveillance
Key information
- Type
- Santé
- Procuring Entity
- OMS
- Location
- 🌍 XX
- Estimated Value
- Not disclosed
- Language of Notice
- English
Description
REOI for WHO Evaluation of lateral flow immunoassays (LFTs) for Detection of Rubella IgM for Surveillance
WHO
REOI for WHO Evaluation of lateral flow immunoassays (LFTs) for Detection of Rubella IgM for Surveillance
Request for EOI
Reference:
2026-EOI-BP-23_ Rubella
Beneficiary countries or territories:
Multiple destinations (see the Countries or territories tab)
Registration level:
Basic
Published on:
27-Feb-2026
Deadline on:
15-Apr-2026 17:00 (GMT 1.00)
Description
The World Health Organization (WHO) invites vendors to submit an Expression of Interest (EOI) for a WHO EVALUATION OF LATERAL FLOW IMMUNOASSAYS FOR THE DETECTION OF RUBELLA IgM FOR SURVEILLANCE which address the following objectives:
Ensure continued availability of Rubella in vitro diagnostics that enable early outbreak detection and assessment of Rubella risks.
Improve access to accurate, reliable Rubella LFTs in high‑risk countries to support timely outbreak response and vaccination planning.
Assess whether commercial products meet WHO standards for safety, quality, and performance for use in Rubella surveillance.
Include eligible LFTs that are single‑use, inst
Tender Timeline
Publication
Pending
Evaluation & Award
Pending
Contract Signature
Pending
Procuring Entity
- Procuring Entity
- OMS